Centene Corporation is an American for-profit healthcare company based in the Greater St. Louis area, which is an intermediary for government-sponsored and privately insured healthcare programs. Centene ranked No. 23 on the 2025 Fortune 500.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| CNC | CENTENE CORP | 2026-02-17 19:50:41 | 41.23 | 0 | 0 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CNC | 0001071739 | CENTENE CORP | US15135B1017 | 549300Z7JJ4TQSQGT333 | 041406317 | NYSE | 6324 | Hospital & Medical Service Plans | 1231 | DE | 7700 FORSYTH BLVD. | ST LOUIS | MO | 63105 | UNITED STATES | US | 3147254477 | 7700 FORSYTH BLVD., ST LOUIS, MO, 63105 | 7700 FORSYTH BLVD., ST LOUIS, MO, 63105 | — | Managed healthcare | 1984 | Sarah London | 60,500 | https://www.centene.com/ | 34,900,000,000 | 623,120,000 | 491,518,000 | Centene Corporation is an American for-profit healthcare company based in the Greater St. Louis area, which is an intermediary for government-sponsored and privately insured healthcare programs. Centene ranked No. 23 on the 2025 Fortune 500. | 2026-02-12 15:49:16 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 34,900,000,000 | -1,900,000,000 | -5.163 | 496,044,000 | -38,819,000 | -7.2577 |
| 2023 | 36,800,000,000 | -12,400,000,000 | -25.2033 | 534,863,000 | -16,401,559 | -2.9753 |
| 2022 | 49,200,000,000 | 6,700,000,000 | 15.7647 | 551,264,559 | -31,601,311 | -5.4217 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Kenneth J. Fasola | President | 2024 | 1,100,000 | 0 | 6,229,423 | 1,598,000 | 95,778 | 9,023,201 |
| Christopher A. Koster | Secretary, General Counsel | 2024 | 750,000 | 0 | 2,920,884 | 1,352,250 | 40,404 | 5,063,538 |
| Sarah M. London | Chief Executive Officer | 2024 | 1,400,000 | 0 | 14,630,132 | 4,289,125 | 282,891 | 20,602,148 |
| Andrew L. Asher | Chief Financial Officer | 2024 | 1,025,000 | 0 | 7,179,353 | 2,779,925 | 198,134 | 11,182,412 |
| Susan R. Smith | Chief Operating Officer | 2024 | 696,154 | 0 | 1,654,307 | 1,099,923 | 72,068 | 3,522,452 |
| Fiscal Year | Employee Count |
|---|---|
| 2022 | 15,000 |
| 2020 | 71,300 |
| 2019 | 56,600 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 194,777,000,000 | 163,071,000,000 | 153,999,000,000 |
| Cost Of Revenue | 2,670,000,000 | 2,729,000,000 | 3,564,000,000 |
| Gross Profit | 14,209,000,000 | 17,069,000,000 | 17,637,000,000 |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 12,904,000,000 | 12,400,000,000 | 12,563,000,000 |
| Operating Expenses | 202,400,000,000 | 159,896,000,000 | 151,069,000,000 |
| Operating Income | -7,623,000,000 | 3,175,000,000 | 2,930,000,000 |
| Net Income | -6,674,000,000 | 3,305,000,000 | 2,702,000,000 |
| Earnings Per Share Basic | -13.53 | 6.33 | 4.97 |
| Earnings Per Share Diluted | -13.53 | 6.31 | 4.95 |
| Weighted Average Shares Outstanding Basic | 493,116,000 | 521,790,000 | 543,319,000 |
| Weighted Average Shares Outstanding Diluted | 493,116,000 | 523,744,000 | 545,704,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 17,888,000,000 | 14,063,000,000 | 17,193,000,000 |
| Marketable Securities Current | 2,432,000,000 | 2,622,000,000 | 2,459,000,000 |
| Accounts Receivable | 18,105,000,000 | 19,713,000,000 | 15,532,000,000 |
| Inventories | — | — | — |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 1,945,000,000 | 1,601,000,000 | 5,572,000,000 |
| Total Assets Current | 40,370,000,000 | 37,999,000,000 | 40,756,000,000 |
| Marketable Securities Non Current | 17,035,000,000 | 17,429,000,000 | 16,286,000,000 |
| Property Plant And Equipment | 2,037,000,000 | 2,067,000,000 | 2,019,000,000 |
| Other Assets Non Current | 528,000,000 | 593,000,000 | 535,000,000 |
| Total Assets Non Current | 36,377,000,000 | 44,446,000,000 | 43,885,000,000 |
| Total Assets | 76,747,000,000 | 82,445,000,000 | 84,641,000,000 |
| Accounts Payable | 13,774,000,000 | 13,174,000,000 | 16,420,000,000 |
| Deferred Revenue | 736,000,000 | 661,000,000 | 715,000,000 |
| Short Term Debt | 50,000,000 | 110,000,000 | 119,000,000 |
| Other Liabilities Current | 172,000,000 | 243,000,000 | 417,000,000 |
| Total Liabilities Current | 36,696,000,000 | 34,261,000,000 | 36,716,000,000 |
| Long Term Debt | 17,493,000,000 | 18,640,000,000 | 17,962,000,000 |
| Other Liabilities Non Current | 1,811,000,000 | 2,567,000,000 | 3,618,000,000 |
| Total Liabilities Non Current | 19,995,000,000 | 21,674,000,000 | 21,969,000,000 |
| Total Liabilities | 56,691,000,000 | 55,935,000,000 | 58,685,000,000 |
| Common Stock | 1,000,000 | 1,000,000 | 1,000,000 |
| Retained Earnings | 8,674,000,000 | 15,348,000,000 | 12,043,000,000 |
| Accumulated Other Comprehensive Income | -58,000,000 | -504,000,000 | -652,000,000 |
| Total Shareholders Equity | 19,953,000,000 | 26,410,000,000 | 25,840,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 1,275,000,000 | 1,241,000,000 | 1,293,000,000 |
| Share Based Compensation Expense | 204,000,000 | 212,000,000 | 216,000,000 |
| Other Non Cash Income Expense | — | -16,000,000 | -172,000,000 |
| Change In Accounts Receivable | — | — | — |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | 230,000,000 | -46,000,000 | -5,000,000 |
| Change In Accounts Payable | -657,000,000 | -528,000,000 | 3,398,000,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 5,088,000,000 | 154,000,000 | 8,053,000,000 |
| Purchases Of Marketable Securities | 4,541,000,000 | 7,183,000,000 | 6,622,000,000 |
| Sales Of Marketable Securities | 5,780,000,000 | 5,785,000,000 | 5,523,000,000 |
| Acquisition Of Property Plant And Equipment | 767,000,000 | 644,000,000 | 799,000,000 |
| Acquisition Of Business | — | 0 | 0 |
| Other Investing Activities | — | 0 | 0 |
| Cash From Investing Activities | 472,000,000 | -1,052,000,000 | -1,191,000,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 1,599,000,000 | 321,000,000 | 85,000,000 |
| Issuance Of Common Stock | 37,000,000 | 46,000,000 | 44,000,000 |
| Repurchase Of Common Stock | 475,000,000 | 3,124,000,000 | 1,633,000,000 |
| Issuance Of Long Term Debt | 750,000,000 | 1,300,000,000 | 2,335,000,000 |
| Repayment Of Long Term Debt | 1,895,000,000 | 622,000,000 | 2,316,000,000 |
| Other Financing Activities | -19,000,000 | -6,000,000 | 0 |
| Cash From Financing Activities | -1,621,000,000 | -2,406,000,000 | -1,658,000,000 |
| Change In Cash | 3,939,000,000 | -3,296,000,000 | 5,172,000,000 |
| Cash At End Of Period | 17,888,000,000 | 14,063,000,000 | 17,193,000,000 |
| Income Taxes Paid | 448,000,000 | 1,002,000,000 | 883,000,000 |
| Interest Paid | 647,000,000 | 688,000,000 | 688,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -13.53 | 6.33 | 4.97 |
| Price To Earnings Ratio | -3.0414 | 9.5703 | 14.9316 |
| Earnings Growth Rate | -313.7441 | 27.3642 | 137.799 |
| Price Earnings To Growth Ratio | 0.0097 | 0.3497 | 0.1084 |
| Book Value Per Share | 40.672 | 50.8059 | 47.773 |
| Price To Book Ratio | 1.0118 | 1.1924 | 1.5534 |
| Ebitda | -4,273,000,000 | 6,250,000,000 | 5,603,000,000 |
| Enterprise Value | 19,946,723,400 | 36,297,038,200 | 41,207,702,990 |
| Dividend Yield | 0.0788 | 0.0102 | 0.0021 |
| Dividend Payout Ratio | -0.2396 | 0.0971 | 0.0315 |
| Debt To Equity Ratio | 0.8792 | 0.71 | 0.6997 |
| Capital Expenditures | 1,245,000,000 | 1,289,000,000 | 880,000,000 |
| Free Cash Flow | 3,843,000,000 | -1,135,000,000 | 7,173,000,000 |
| Return On Equity | -0.3345 | 0.1251 | 0.1046 |
| One Year Beta | 0.1597 | 0.2697 | 0.4794 |
| Three Year Beta | 0.2583 | 0.5099 | 0.5576 |
| Five Year Beta | 0.4215 | 0.822 | 0.8808 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Asher Andrew Lynn | Chief Financial Officer | 2026-01-26 | 173,573 | A | 831,215 |
| CASSO KATIE | Corporate Controller & CAO | 2026-01-26 | 26,036 | A | 122,371 |
| KOSTER CHRISTOPHER | Secretary & General Counsel | 2026-01-26 | 126,925 | A | 388,861 |
| LONDON SARAH | Director, Chief Executive Officer | 2026-01-26 | 520,720 | A | 1,365,995 |
| MCNALLY TANYA M | Chief People Officer | 2026-01-26 | 74,311 | A | 133,080 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Julia Letlow | 2026-01-13 | LA05 | Purchase | 2025-04-14 | — | $1,001 - $15,000 |
| Julia Letlow | 2026-01-13 | LA05 | Sale | 2025-08-08 | — | $1,001 - $15,000 |
| Gilbert Cisneros | 2025-09-12 | CA31 | Purchase | 2025-08-05 | — | $1,001 - $15,000 |
| Valerie Hoyle | 2025-09-12 | OR04 | Purchase | 2024-10-29 | Spouse | $1,001 - $15,000 |
| Tim Moore | 2025-09-03 | NC14 | Purchase | 2025-08-08 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Point72 Asset Management, L.P. | 2025-12-31 | 33,302,695 | 809,300 | 41.15 |
| Point72 Asset Management, L.P. | 2025-12-31 | 40,878,410 | 993,400 | 41.15 |
| PFM Health Sciences, LP | 2025-12-31 | 15,320,145 | 372,300 | 41.15 |
| PFM Health Sciences, LP | 2025-12-31 | 29,851,198 | 725,424 | 41.15 |
| Man Group plc | 2025-12-31 | 25,768,335 | 626,205 | 41.15 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 2025-12-31 | Institutional Class Shares | WILCX | 43,000 | 1,769,450 | 1.2096 |
| WASATCH FUNDS TRUST | 2025-12-31 | Investor Class shares | FMIEX | 43,000 | 1,769,450 | 1.2096 |
| EMPOWER FUNDS, INC. | 2025-12-31 | Institutional Class | MXUGX | 720,000 | 644,067.35 | 0.0464 |
| EMPOWER FUNDS, INC. | 2025-12-31 | Institutional Class | MXUGX | 545,000 | 501,527.74 | 0.0361 |
| EMPOWER FUNDS, INC. | 2025-12-31 | Institutional Class | MXUGX | 538,000 | 521,829.72 | 0.0376 |